Evaluation and Management of Irregular Menstruation

Begin by ruling out pregnancy, then systematically evaluate for underlying gynecological pathology, endocrine disorders (particularly PCOS and thyroid disease), and medication effects before considering treatment options.

Initial Assessment

History - Key Elements

Focus your questioning on:

Menstrual pattern specifics: cycle length, duration of bleeding, volume (number of pad/tampon changes per day), presence of clots
Timing: age at menarche, duration since onset of irregularity, relationship to life events
Associated symptoms: hirsutism, acne, weight changes, galactorrhea, hot flashes, headaches, visual changes
Medications: particularly hormonal contraceptives, antiepileptics, antipsychotics, thyroid medications
Eating/exercise habits: signs of energy deficit or excessive exercise
Psychosocial stressors: significant life changes, mental health concerns
Sexual history: contraceptive needs, pregnancy risk 1, 2, 3

Physical Examination Priorities

Anthropometric measurements: BMI, waist-to-hip ratio (WHR >0.85 suggests PCOS) 4
Hyperandrogenic signs: hirsutism, acne, male-pattern hair loss, clitoromegaly
Thyroid examination: goiter, nodules
Galactorrhea: breast examination for nipple discharge
Pelvic examination (if sexually active or clinically indicated): assess for structural abnormalities, masses 4, 5

Laboratory Evaluation

First-Line Testing (All Patients)

Urine or serum pregnancy test - mandatory first step 1, 2, 3
TSH - exclude thyroid dysfunction 4, 5, 2
Prolactin - morning resting level (not post-stress); abnormal if >20 μg/L 4, 2
FSH and LH - measured days 3-6 of cycle (average of three samples 20 minutes apart):
- LH/FSH ratio >2 suggests PCOS
- FSH >35 IU/L suggests ovarian insufficiency
- LH <7 IU/mL suggests hypothalamic amenorrhea 4, 2, 3

Second-Line Testing (Based on Clinical Suspicion)

Mid-luteal progesterone (day 21 of 28-day cycle): <6 nmol/L indicates anovulation 4
Total testosterone: >2.5 nmol/L abnormal; consider PCOS or other hyperandrogenic disorders 4, 5
Androstenedione: >10.0 nmol/L warrants evaluation for adrenal/ovarian tumor 4
DHEAS: age-specific cutoffs; elevated suggests adrenal pathology 4
Fasting glucose and insulin: glucose/insulin ratio >4 suggests insulin resistance 4, 5

Imaging

Transvaginal ultrasound (days 3-9 of cycle): indicated if:
- Clinical suspicion of PCOS (>10 peripheral 2-8mm cysts in one plane, stromal thickening) 4, 5
- Pelvic mass on examination
- Failed medical management 6
Saline infusion sonohysterography: 96-100% sensitivity for intracavitary lesions if structural pathology suspected 6

Common Diagnoses and Management

Polycystic Ovary Syndrome (PCOS)

Diagnosis requires 2 of 3 Rotterdam criteria: androgen excess, ovulatory dysfunction, or polycystic ovaries (after excluding other disorders) 5

Management approach:

First-line for menstrual irregularity and hirsutism/acne: Hormonal contraceptives 5
For metabolic abnormalities: Metformin improves menstrual irregularities and glycemic parameters but has limited benefit for hirsutism/acne 5
For infertility: Clomiphene is first-line 5
Lifestyle modification: beneficial in overweight/obese patients for metabolic health 5
Screen for: diabetes (OGTT or HgbA1c), dyslipidemia, obstructive sleep apnea, mood disorders, endometrial cancer risk 5

Functional Hypothalamic Amenorrhea

Suggested by low LH (<7 IU/mL), history of energy deficit, excessive exercise, or psychosocial stress 4, 2, 3

Management:

Address underlying cause: nutritional rehabilitation, reduce exercise intensity, stress management
Evaluate and treat low bone density
Consider hormone replacement if bone density compromised 2, 3

Hyperprolactinemia

Prolactin >20 μg/L requires:

Rule out hypothyroidism (TSH)
Brain MRI to exclude pituitary adenoma
Review medications (antipsychotics, metoclopramide, antiepileptics can elevate prolactin) 4

Primary Ovarian Insufficiency

FSH >35 IU/L with amenorrhea suggests premature ovarian failure

Karyotype if age <40 years
Hormone replacement therapy until average age of natural menopause (~51 years)
Counsel regarding unpredictable ovarian function and fertility 2, 3

Thyroid Dysfunction

Treat per TSH results; menstrual irregularity typically resolves with thyroid hormone normalization 4, 5

When Underlying Pathology is Excluded

For Contraceptive-Related Irregular Bleeding

If patient is using hormonal contraception and bleeding is bothersome:

Implant/DMPA users 7, 8:

NSAIDs: 5-7 days during bleeding episodes
Hormonal treatment: low-dose COCs or estrogen for 10-20 days (if medically eligible)

Extended/continuous CHC users 8, 7:

Hormone-free interval: 3-4 consecutive days (not during first 21 days, not more than once monthly)

Copper IUD users 7:

NSAIDs: 5-7 days for spotting or heavy bleeding

Critical Pitfalls to Avoid

Never assume irregular bleeding is "normal" without pregnancy test - even in patients using contraception or with amenorrhea 1
Don't overlook medication effects: antiepileptics (carbamazepine, phenobarbital, phenytoin) alter sex hormone metabolism and can cause menstrual irregularity 4
PCOS diagnosis requires exclusion of other disorders: thyroid disease, hyperprolactinemia, non-classical congenital adrenal hyperplasia, Cushing syndrome 5
Distinguish isolated polycystic ovaries (17-22% of women, benign finding) from PCOS syndrome (requires symptoms and hormonal abnormalities) 4
In adolescents: irregular cycles are common in first 1-3 years post-menarche due to anovulation; however, hyperandrogenism is NOT normal and warrants evaluation 5, 9
Endometrial protection: women with chronic anovulation (PCOS, hypothalamic amenorrhea) require either cyclic progestin or hormonal contraceptives to prevent endometrial hyperplasia/cancer 5
If medical management fails: proceed to imaging (ultrasound, saline infusion sonohysterography) or hysteroscopy to exclude structural lesions (polyps, fibroids, intracavitary pathology) 6

How should I evaluate and manage a patient presenting with irregular menstruation?

Have a follow-up question?